
Dispatch
Emergency departments in France report a 22 percent increase in Covid-19 visits over a single week, sparking urgent questions from families about whether a new wave of infections has arrived, according to reports from Charente Libre and PasseportSanté.
Dr. Amara Solis · 4 Oct 2026

Dispatch
On Sept. 17, 2026, health systems examine the shift from basic body mass indexes toward visceral fat measurements. Deutsche Herzstiftung explores why abdominal measurements reveal distinct cardiac dangers that standard height and weight ratios routinely miss during clinical evaluations.
Dr. Amara Solis · 25 Sept 2026

Dispatch
A medical specialist from Paderborn has taken a seat on an international expert panel as the sole German representative, joining a collaborative scientific effort that spans borders while researchers also explore new therapeutic avenues for neurodegenerative conditions like ALS.
Dr. Amara Solis · 24 Sept 2026

Dispatch
On Sept. 20, 2026, health systems in Spain began deploying advanced therapies for severe brain tumors and lymphoma. Diario de Burgos and elpais.com report on the shift toward personalized care. This transition changes how clinicians target complex malignancies across public hospitals.
Dr. Amara Solis · 20 Sept 2026

Dispatch
Health authorities in Philadelphia and Los Angeles issued public warnings regarding potential measles exposures tied to major transit locations, including <a href="https://6abc.com">Philadelphia International Airport</a> and <a href="https://abc7.com">LA Union Station</a>, following travel by an infected individual.
Dr. Amara Solis · 18 Sept 2026

Infectious Disease
Immunization systems face severe stress as public health data reveals heavy tolls from preventable viral spread.
Dr. Amara Solis · 17 Sept 2026

Infectious Disease & Health Systems
A large study links very hot drinks to a tripled risk of cancer, sparking a sharp public divide between caution and comfort.
Dr. Amara Solis · 10 Sept 2026

Health Systems
New data suggests AI-developed drug candidates and GLP-1 weight-loss medications may influence biological aging, though evidence remains split between mouse models and early human trials.
Dr. Amara Solis · 8 Sept 2026

Preventive Health
Clinicians are fighting a war against male avoidance. The goal is to move screening from a source of fear to a routine of survival.
Dr. Amara Solis · 1 Sept 2026

Health Analysis
The NHS begins the first large-scale mRNA flu jab for seniors, children and pregnant women while clinicians and policymakers argue over safety, cost and public confidence.
Dr. Amara Solis · 1 Sept 2026

Breaking
WHO says the outbreak in the Democratic Republic of the Congo is spreading faster than it can be contained. The vaccines exist. The race is logistics, trust, and time.
Dr. Amara Solis · 29 Aug 2026

Immunization
A measles outbreak reaching Allegheny County is a local fact. The national argument about childhood shots is the weather system that local facts now have to live in.
Dr. Amara Solis · 28 Aug 2026

On file
Trust Crisis Links Cancer Cluster Towns And Measles. This file remains on the issue at this address.
Dr. Amara Solis · 26 Aug 2026

On file
Hrt Timing Mammogram Ai And The Search For Precision In Women’S Midlife Health. This file remains on the issue at this address.
Dr. Amara Solis · 26 Aug 2026

On file
Pakistan’S Nursery Fire Fourteen Newborns Lost To A Hospital’S Neglect. This file remains on the issue at this address.
Dr. Amara Solis · 26 Aug 2026

On file
Two Unvaccinated Adults Die In Pennsylvania Measles Outbreak. This file remains on the issue at this address.
Dr. Amara Solis · 26 Aug 2026

On file
Shingles Vaccine Tied To Lower Dementia And Cardiovascular Risk. This file remains on the issue at this address.
Dr. Amara Solis · 26 Aug 2026

Correction
The Guardian’s Friday file linked xylitol — in gum, toothpaste, jam — to strokes and heart attacks. We first named erythritol, the 2023–24 Cleveland Clinic story. Wrong sweetener. Same class of warning.
Dr. Amara Solis · 26 Aug 2026

The Clinic
On 26 August the FDA approved Rasonque (daraxonrasib), a RAS inhibitor, for adults with metastatic pancreatic adenocarcinoma after prior therapy. The science is first-in-class. The invoice is not a public good.
Dr. Amara Solis · 26 Aug 2026